These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2406 related articles for article (PubMed ID: 23803760)

  • 1. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome.
    Yoshimoto S; Loo TM; Atarashi K; Kanda H; Sato S; Oyadomari S; Iwakura Y; Oshima K; Morita H; Hattori M; Honda K; Ishikawa Y; Hara E; Ohtani N
    Nature; 2013 Jul; 499(7456):97-101. PubMed ID: 23803760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cellular senescence and chronic inflammation].
    Ohtani N
    Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(5):390-7. PubMed ID: 25744638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between Obesity, Gut Microbiome and Hepatocellular Carcinoma Development.
    Hara E
    Dig Dis; 2015; 33(3):346-50. PubMed ID: 26045268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Senescent hepatic stellate cells caused by deoxycholic acid modulates malignant behavior of hepatocellular carcinoma.
    Nguyen PT; Kanno K; Pham QT; Kikuchi Y; Kakimoto M; Kobayashi T; Otani Y; Kishikawa N; Miyauchi M; Arihiro K; Ito M; Tazuma S
    J Cancer Res Clin Oncol; 2020 Dec; 146(12):3255-3268. PubMed ID: 32870388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota: Obesity-induced microbial metabolite promotes HCC.
    Ray K
    Nat Rev Gastroenterol Hepatol; 2013 Aug; 10(8):442. PubMed ID: 23817322
    [No Abstract]   [Full Text] [Related]  

  • 6. Gasdermin D-mediated release of IL-33 from senescent hepatic stellate cells promotes obesity-associated hepatocellular carcinoma.
    Yamagishi R; Kamachi F; Nakamura M; Yamazaki S; Kamiya T; Takasugi M; Cheng Y; Nonaka Y; Yukawa-Muto Y; Thuy LTT; Harada Y; Arai T; Loo TM; Yoshimoto S; Ando T; Nakajima M; Taguchi H; Ishikawa T; Akiba H; Miyake S; Kubo M; Iwakura Y; Fukuda S; Chen WY; Kawada N; Rudensky A; Nakae S; Hara E; Ohtani N
    Sci Immunol; 2022 Jun; 7(72):eabl7209. PubMed ID: 35749514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver cancer: Gut microbiota feeds obesity-induced liver cancer.
    Hutchinson L
    Nat Rev Clin Oncol; 2013 Aug; 10(8):428. PubMed ID: 23836315
    [No Abstract]   [Full Text] [Related]  

  • 8. Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE
    Loo TM; Kamachi F; Watanabe Y; Yoshimoto S; Kanda H; Arai Y; Nakajima-Takagi Y; Iwama A; Koga T; Sugimoto Y; Ozawa T; Nakamura M; Kumagai M; Watashi K; Taketo MM; Aoki T; Narumiya S; Oshima M; Arita M; Hara E; Ohtani N
    Cancer Discov; 2017 May; 7(5):522-538. PubMed ID: 28202625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiome-obesity-liver cancer interaction: senescence of hepatic stellate cells and bile acids play new roles.
    Seki E
    Gastroenterology; 2014 Mar; 146(3):860-1. PubMed ID: 24468171
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer: An acidic link.
    Devkota S; Turnbaugh PJ
    Nature; 2013 Jul; 499(7456):37-8. PubMed ID: 23803768
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatic stellate cell activation and senescence induced by intrahepatic microbiota disturbances drive progression of liver cirrhosis toward hepatocellular carcinoma.
    Liu B; Zhou Z; Jin Y; Lu J; Feng D; Peng R; Sun H; Mu X; Li C; Chen Y
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 34996812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond liver fibrosis: hepatic stellate cell senescence links obesity to liver cancer by way of the microbiome.
    Shackel NA; Vadas MA; Gamble JR; McCaughan GW
    Hepatology; 2014 Jun; 59(6):2413-5. PubMed ID: 24273014
    [No Abstract]   [Full Text] [Related]  

  • 13. Phenotypes and ontogeny of senescent hepatic stellate cells in metabolic dysfunction-associated steatohepatitis.
    Yashaswini CN; Qin T; Bhattacharya D; Amor C; Lowe S; Lujambio A; Wang S; Friedman SL
    J Hepatol; 2024 Aug; 81(2):207-217. PubMed ID: 38508241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer.
    Lade A; Noon LA; Friedman SL
    Curr Opin Oncol; 2014 Jan; 26(1):100-7. PubMed ID: 24275855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reply: To PMID 23803760.
    Hara E
    Gastroenterology; 2014 Mar; 146(3):861. PubMed ID: 24468169
    [No Abstract]   [Full Text] [Related]  

  • 16. Diet-Induced Obesity Enhances Progression of Hepatocellular Carcinoma through Tenascin-C/Toll-Like Receptor 4 Signaling.
    Benbow JH; Thompson KJ; Cope HL; Brandon-Warner E; Culberson CR; Bossi KL; Li T; Russo MW; Gersin KS; McKillop IH; deLemos AS; Schrum LW
    Am J Pathol; 2016 Jan; 186(1):145-58. PubMed ID: 26603137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma.
    Song Q; Zhang X; Liu W; Wei H; Liang W; Zhou Y; Ding Y; Ji F; Ho-Kwan Cheung A; Wong N; Yu J
    J Hepatol; 2023 Dec; 79(6):1352-1365. PubMed ID: 37459922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretome of senescent hepatic stellate cells favors malignant transformation from nonalcoholic steatohepatitis-fibrotic progression to hepatocellular carcinoma.
    Zhou Y; Zhang L; Ma Y; Xie L; Yang YY; Jin C; Chen H; Zhou Y; Song GQ; Ding J; Wu J
    Theranostics; 2023; 13(13):4430-4448. PubMed ID: 37649614
    [No Abstract]   [Full Text] [Related]  

  • 19. Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis.
    Xie G; Wang X; Huang F; Zhao A; Chen W; Yan J; Zhang Y; Lei S; Ge K; Zheng X; Liu J; Su M; Liu P; Jia W
    Int J Cancer; 2016 Oct; 139(8):1764-75. PubMed ID: 27273788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut-liver axis-mediated mechanism of liver cancer: A special focus on the role of gut microbiota.
    Ohtani N; Hara E
    Cancer Sci; 2021 Nov; 112(11):4433-4443. PubMed ID: 34533882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 121.